News and Comments

IDERA (IDRA): GOOD NEWS OFFSET SOMEWHAT BY SKEPTICISM NOT PESSIMISM

  Monday, March 04, 2013

Forgetting about Idera Pharmaceuticals (IDRA) seems to make its value sink, but failed to make it disappear. With a stock that sells at less than a three quarter of a dollar and a market of $20 million, lower than a new comer biotech having drugs still in preclinical lab testing, the firm was capable of drawing investors’ attention, riding new data about an attractive possibility of beating all existing approaches to treating psoriasis. The surprising data, which bring hopes in treating other autoimmune diseases, in addition to psoriasis were presented by James G. Krueger, M.D., PhD, of The Rockefeller University, at the Late-Breaking Research Symposium on March 2nd, 2013, during the American Academy of Dermatology Annual Meeting. More...


Recent Postings


Archive


Tags

Sanofi (SNY) Benlysta (belimumab) Prosensa (RNA) Vertex (VRTX) ABBVIE (ABBV) NOVOCURE (NVCR) Auspex (ASPX) HALOZYME (HALO) ACADIA (ACAD) PTC Therapeutics (PTCT) Bellicum (BLCM) Spike Therapeutics (ONCE) GUARDIAN HEALTH Alnylam (ALNY) Elan (ELN) Sanofi (SNA) Ionis (IONS) Herceptin Anacor (ANAC) Merck (MRK) Ridaforolimus Human Genome Sciences (HGSI) BIOMARIN (BMRN) JUNO (JUNO) Agenus (AGEN) Editas (EDIT) ISIS (ISIS) MODERNA Sangamo (SGMO) Jazz Pharmaceuticals (JAZZ) Advaxis (ADXS) Intermune (ITMN) Sanofi-Aventis (SAN) Multiple Myeloma Dendreon (DNDN) Rapamune SERES THERAPEUTICS (MCRB) ARGOS (ARGS) CRISPR Therapeutics (CRSP) Telaprevir Roche (RHHBY) Biocryst (BCRX) NEKTAR (NKTR)) Global Cell Therapeutics (GBT) Intrexon (XON) Prolor Biotech (PBTH) Amgen (AMGN) VANDA (VNDA) OSI (OSIP) Revlimid (lenolidamide) TOKAI (TKAOI) Exelixis (EXEL) Aimmune Therapeutics (AIMT) INNOVIVA (INVA) Galena (GALE) galapagos (GLPG) Vitae Pharmaceuticals (VTAE) Dynavax (DVAX) IDERA (IDRA) Endometrial Cancer Idenix (IDIX) Velcade (bortezomib) REGULUS (RGLS) ImmunoGen (IMGN) Theravance Bio Pharma (TBPH) Illumina (ILMN) Alder Biopharmaceuticals (ALDR) CompuGen (CGEN) Tysabri Seattle Genetics (SGEN) Intercept (ICPT) Incyte (INCY) Cytokinetics (CYTK) Sarepta (SRPT) Ziofpharm (ZIOP) Pluristem (PSTI) Anadys (ANDS) Theravance (THRX) Trastuzumab-DM1 SYNTA (SNTA) Valeant Pharmaceuticals International (VRX) Bristol-Myers Squibb (BMY) Sequenom (SQNM) Ariad (ARIA) Regeneron (REGN) Array Pharmaceuticals (ARRY) Adaptimmune (ADAP) Zerenex Inovio (INO) Micromet (MITI) ARCA (ABIO) Human Longevity (HLI) Genentech KERYX (KERX) ZALTRAP™ Xoma (XOMA) Biogen Idec (BIIB) Onyx (ONXX) KITE (KITE) GlaxoSmithKline (GSK) C4 Therapeutics Gilead (GILD) AERIE PHARMACEUTICALS SUNESIS PHARMACEUTICALS (SNSS) Abbott Laboratories (ABT) NANTKWEST (NK) Roche (ROCHE) RenenxBio (RGNX) AstraZeneca (AZN) Mirati Therapeutics (MRTX) Agenus (AGEN AGOS (ARGS) ADVENTRIX (ANX)